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Induction of Dominant Mutations That
Cause Skeletal Malformations in Mice
by Paul B. Selby*
A new approach for estimating genetic risk to humans from radiation is based upon an analysis of the
frequency ofinduction ofdominant mutations that cause skeletal abnormalities in mice. The main goal of
this work isto improve estimates ofthe effect that an increase in the mutation frequency would have upon
the incidence ofserious genetic diseases in humans. The data obtained relate to dominant and irregularly
inherited conditions in humans, which together constitute the great majority of human genetic diseases.
The skeletal method could be used in chemical mutagenesis research in order to make a much more
accurate risk-benefit analysis. A more likely application, however, is to provide a relatively quick and
easy mammalian testing procedure for identifying mutagens. Dominant mutations at an unknown, but
probably large, number ofgenetic loci could be detected. The relatively quick and easy procedure, which
is described, has not yet been tested.
Most mutagenesis research is concerned with the
question of whether a given chemical or physical
insult can induce mutations and, if so, to what ex-
tent or by what mechanisms. With such data alone,
it is very difficult to assess genetic risk. This paper
describes a relatively new approach in mutagenesis
research in which the emphasis is on the damage
caused by the mutations. The endpoint recorded is
the frequency of dominant mutations, detected in
the first generation after treatment, that cause
skeletal abnormalities in mice. Perhaps the biggest
gap in knowledge required for estimating genetic
risk to humans from radiation has been the lack of
estimates ofheritable damage in the first generation
following irradiation in a mammal. The results de-
scribed in this paper show an effective way to ac-
quire such information.
Results ofa large experiment by Selby and Selby
are published elsewhere (1), and only a brief de-
scription will be given here. Male mice were ex-
posed to 100 + 500 R of60 R/min gamma radiation,
with a 24-hr interval between fractions. After wait-
ing long enough to ensure that the spermatogonial
mutation frequency would be obtained, these mice
were mated and their F1 sons collected. The F1 sons
were raised and permitted to breed before they were
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killed and their skeletons were prepared for study.
Alizarin-stained skeleton preparations were exam-
ined in detail through a dissecting microscope. Ifan
abnormality suggested the presence of a mutation,
some of the offspring of the F1 were prepared for
skeletal study in order to determine if the abnor-
mality was transmitted. By means of this breeding
test, it was possible to prove that abnormalities
were caused by a dominant mutation. Furthermore,
enough offspring ofthe Fl's were usually produced
to enable mutant lines to be established for a more
detailed genetical study.
Ofthe 2646 Fl's examined, 37 were concluded to
be mutants. Ofthe 37, 31 were proved to be mutants
by means of the breeding test and six, having no
progeny, were concluded to be mutants on the basis
ofpresumed mutation criteria. Almost all regions of
the skeleton were affected by one or more of the
mutations. The malformations recorded were those
easily observable through a dissecting microscope.
They consisted mainly of fusions of bones, too
many or too few bones, and easily noticeable
changes in the shapes or relative positions ofbones.
For three ofthe mutations, the only skeletal abnor-
mality was a marked decrease in body size. Of the
31 proved mutations, 5 caused only one specific
anomaly, 19 caused 2-5 anomalies, five caused 6-10
anomalies, and two caused 11-13 anomalies. Some
of the anomalies were common to several different
syndromes. Essentially all of the mutations have
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anomalies that they cause.
The mutations are described in detail in other pa-
pers (2, 3). Only some of the effects of one of the
mutations will be described in this paper. This de-
scription will give a better idea of the types of ef-
fects caused by the dominant skeletal mutations.
Mutation 320 causes all heterozygotes to have in-
complete clavicles and ajagged edge at the anterior
end oftheir nasals. In addition, almost all heterozy-
gotes have a hole in the skull between the frontals.
One effect which illustrates the occurrence of in-
complete penetrance is that the interparietal bone is
normal in 17% of the mice heterozygous for this
mutation, but in 55% ofthe carriers it is divided into
two pieces, in 24% into three pieces, in 3% into four
pieces, and in 1% into five pieces. This mutation is
especially interesting since it provides an excellent
model ofthe autosomal dominantdisease in humans
called cleidocranial dysplasia.
Our experiment was patterned after the pioneer-
ing experiments of Ehling (4). The two main differ-
ences were that a breeding test was used to permit
proof of transmissibility and a much larger sample
was collected for a single radiation treatment. Ehl-
ing's experiments showed clearly that radiation in-
duces a relatively high frequency of dominant mu-
tations causing skeletal malformations. It is some-
what surprising that his results were not given more
attention by those making risk estimates. This re-
sulted, perhaps, from skepticism that his presumed
mutations were mutations. The main question that
our experiment was designed to answer was
whether the types of malformations that Ehling
thought were caused by dominant mutations were
transmissible. Besides confirming Ehling's conclu-
sion that radiation induces a relatively high fre-
quency of dominant mutations, our experiment
shows that at least most of Ehling's presumed
dominant mutations must have been mutations.
There is a tendency for some nongeneticists to
confuse our results with teratogenic effects. Forthis
reason, it is important to stress the differences. The
F1 mice with malformations in our experiment were
never irradiated; rather, it was their fathers which
were irradiated. The malformations are inherited
from generation to generation, demonstrating that
they resultfrom true mutations. As anillustration, if
it is possible to maintain one ofthe mutations for 50
generations in the laboratory, it will still cause the
malformations even though neither the mice show-
ing them nor their ancestors for 50 generations have
been irradiated. In contrast, if a mouse has a
skeletal malformation of purely teratogenic origin
(perhaps caused by irradiation during the period of
major organogenesis), the descendants of this
mouse in even the first generation would not have
the malformation.
In an earlier paper (1), we suggested a way in
which the mutation rate obtained in our experiment
can be used to estimate the genetic risk to humans
of having an induced dominant or irregularly inher-
ited serious genetic disease in the first generation
following increased exposure to radiation. Since
these two categories of disease encompass about
95% of mankind's current load of serious genetic
diseases (5), it is easy to see that the type of data
accumulated using the skeletal approach has major
implications for estimates of genetic risk.
It is worth noting, in more detail, why the data on
dominant skeletal mutations in mice relate to domi-
nant and irregularly inherited conditions in humans.
Any mutations having complete penetrance, or al-
most complete penetrance, for recognizable mal-
formations in heterozygotes would be considered
dominants in any species. Mutations in mice having
low penetrance for severe malformations in
heterozygotes but causing no effects with complete
or nearly complete penetrance that would be recog-
nizable ifthey occurred in humans, would be equiv-
alent to mutations in humans that cause severe ef-
fects that are presently thought to be irregularly in-
herited, but that are in reality the result of single
dominant mutations with low penetrance. In hu-
mans, it would be much more difficult than in mice
to recognize and confirm that a malformation is
caused by a dominant mutation having incomplete
penetrance. An unknown fraction of the irregularly
inherited conditions in humans results from other
modes of inheritance than dominants with incom-
plete penetrance; however, the skeletal approach
relates to that fraction of the irregularly inherited
conditions that would show a significant increase in
incidence in the early generations following a
change in the mutation frequency.
Our experiment was designed to measure overall
damage to one body system caused by radiation-
induced dominant mutations. Experiments of this
type, involving time-consuming analyses of entire
skeletons (about 25 min per F1 individual) and
breeding tests, will be used for making further re-
finements in estimates ofgenetic hazard to humans
from radiation. It is important to consider what appli-
cations, if any, such a labor-intensive method might
have for the assessment ofgenetic risk for the mul-
titude of possible chemical mutagens. The im-
provement our data is making in knowledge about
how an increase in the mutation frequency is related
to an increase in genetic disease should be of great
use to those facing this question forchemicals in the
coming years. If a chemical of great potential use-
fulness to mankind were found to be a mutagen in
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(6), further testing ofthe chemical in a skeletal mu-
tation experiment of the type described above
would permit a much more accurate comparison of
benefit versus risk. The reason that such a test
should be performed for that particular chemical is
that the proportion of mutations induced by it re-
sulting in malformations might be markedly differ-
ent from the proportions found for mutations in-
duced by radiation or by other chemicals. It seems
likely that the skeletal method, in the form de-
scribed so far, would only be used for mutagenic
chemicals with potentially great benefits.
The skeletal method, in a modified form, may
have much wider application to chemical
mutagenesis research. The modification with the
greatest potential is termed the sensitive-indicator
approach. It derives its name from the suggestion in
our experiment that a few specific malformations
may be sensitive indicators of the presence of mu-
tations. In our experiment, only three of the 2646
F,'s had an additional thoracic vertebra, and all
three ofthese were proved to be mutants. Similarly,
only three had a fusion of the triangular and
pisiform, only two had the vertebra prominens
shifted to the third thoracic vertebra, only two had a
cervical rib. All seven ofthese mice were also found
to be mutants. (Most of these 10 mutations cause
additional malformations.) The finding that so few
ofthe F,'s had any ofthese four malformations and
that all mice with any of these malformations were
mutants suggests that a large proportion, or perhaps
all, of the F1's with these malformations are mu-
tants. Such malformations would be sensitive indi-
cators of mutations. These data suggest that by
using only a small number of sensitive indicators it
may be possible to identify an important fraction of
the total mutations that cause skeletal malforma-
tions. In our experiment, had we assumed that all
F,'s having any of the four malformations listed
were mutants, we would have found 10 of the 37
total mutations by that means alone.
In a sensitive-indicator mutation experiment, the
incidence in the F1 generation of only a small
number of specific malformations, the sensitive in-
dicators, would be determined forboth a chemically
treated group and its concurrent control. If the
chemical did induce dominant mutations that cause
malformations, the incidence ofsensitive indicators
would be much higher in the experimental group
than in the control group. A sensitive-indicator ex-
periment would be cheap and easy compared to the
skeletal method used in making overall risk assess-
ments. The time taken to examine a skeleton would
be reduced by a factor of about 20; there would be
no expensive and time-consuming breeding test;
and the experiment could be performed by a techni-
cian having little training. Besides having these ad-
vantages, it would still be measuring dominant
damage in a mammal resulting from mutations at an
unknown, but probably large, number of genetic
loci. This approach obviously has the potential of
being of considerable usefulness in chemical
mutagenesis testing.
It should be emphasized, however, that
sensitive-indicator results would, at this time, be
meaningless in the absence of a concurrent control.
There is not yet enough evidence that the suspected
indicator traits result solely from mutations. Such
evidence can only be acquired as a by-product of
further research ofthe type described in the first part
of this paper. Furthermore, much work would be
necessary to identify the malformations that are sen-
sitive indicators in a different strain or under differ-
ent laboratory conditions. In other words, much
prior work is necessary in order to design a
sensitive-indicator experiment thatwould have much
chance of success. We hope to test this approach in
the near future.
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